Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
about
Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Nanotechnology for the detection and therapy of stroke.Inflammatory cytokines in atherosclerosis: current therapeutic approaches.Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.QbD approach to investigate product and process variabilities for brain targeting liposomes.The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective.
P2860
Q35249558-4529957D-0E16-445E-927A-C851843C5D0DQ36598388-5AA432DA-9EC0-4B95-9DD5-62EBD46852A5Q37101142-E8741ED2-26DB-401B-A497-D771CE4F9C38Q37544674-293E583E-2EFD-4ECE-9BC3-B768F33EC7C9Q38201415-3662CBE6-82C2-454E-A276-26D5D191645FQ38722298-76373C39-C4CD-4035-BFFE-11C402CE7FDBQ38801539-81FAAD0B-8465-4E79-9E01-E048D3BCE576Q38891729-493F2F65-DE33-4E7E-A363-FA7AB8FFAE41Q42280481-9D75C18A-F1C9-43AB-BF98-5A31339EFB06Q47866518-02B6EF2E-023D-4BE2-88EB-A5B8673938C9Q48488102-9EFFFE07-87E9-4F87-B5DC-6D6C25E0237EQ51243846-10B04CBF-6ABF-4ED9-8FBA-CB3BC95DA258Q51639424-3D8FF507-3660-4E27-B0B8-7653A64684A9Q51769372-1DD3148A-7662-4045-8A66-FC7803589B71Q55035936-8D5D4AE9-64E8-44FD-906F-A61BA000305A
P2860
Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@ast
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@en
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@nl
type
label
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@ast
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@en
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@nl
prefLabel
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@ast
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@en
Interleukin-10: an anti-inflam ...... sions via PEGylated liposomes.
@nl
P2093
P2860
P50
P356
P1476
Interleukin-10: an anti-inflam ...... esions via PEGylated liposomes
@en
P2093
Anna Lukschal
Caroline Stremnitzer
Caroline Vonach
Daniela Frascione
Gunter Almer
Harald Mangge
Isabella Pali-Schöll
P2860
P304
P356
10.1021/MP300316N
P407
P577
2012-12-04T00:00:00Z